Jalil, Angel Nadiyah D.
HRN: 20-79-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
07/31/2023
08/04/2023
ORAL
5ml
BID
Ascariasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes